Dimensional Fund Advisors’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-30,334
| Closed | -$225K | – | 3275 |
|
|
2026
Q1 | $225K | Buy |
30,334
+3,791
| +14% | +$24.7K | ﹤0.01% | 3056 |
|
|
2025
Q4 | $167K | Buy |
26,543
+3,312
| +14% | +$19.3K | ﹤0.01% | 3104 |
|
|
2025
Q3 | $90.6K | Sell |
23,231
-6,739
| -22% | -$27.6K | ﹤0.01% | 3200 |
|
|
2025
Q2 | $137K | Sell |
29,970
-2,340
| -7% | -$10K | ﹤0.01% | 3155 |
|
|
2025
Q1 | $158K | Hold |
32,310
| – | – | ﹤0.01% | 3153 |
|
|
2024
Q4 | $217K | Buy |
+32,310
| New | +$241K | ﹤0.01% | 3154 |
|
|
2023
Q3 | – | Sell |
-2,240
| Closed | -$54.9K | – | 3487 |
|
|
2023
Q2 | $54.9K | Sell |
2,240
-6,136
| -73% | -$160K | ﹤0.01% | 3400 |
|
|
2023
Q1 | $262K | Sell |
8,376
-35,968
| -81% | -$2.08M | ﹤0.01% | 3151 |
|
|
2022
Q4 | $3.12K | Sell |
44,344
-26,433
| -37% | -$1.96M | ﹤0.01% | 2586 |
|
|
2022
Q3 | $6.09M | Buy |
70,777
+32,373
| +84% | +$3.15M | ﹤0.01% | 2355 |
|
|
2022
Q2 | $3.18M | Buy |
38,404
+10,611
| +38% | +$936K | ﹤0.01% | 2599 |
|
|
2022
Q1 | $4.62M | Buy |
27,793
+213
| +0.8% | +$30.6K | ﹤0.01% | 2560 |
|
|
2021
Q4 | $4.61M | Buy |
27,580
+10,693
| +63% | +$1.21M | ﹤0.01% | 2584 |
|
|
2021
Q3 | $1.46M | Buy |
16,887
+13,508
| +400% | +$894K | ﹤0.01% | 2941 |
|
|
2021
Q2 | $183K | Buy |
+3,379
| New | +$192K | ﹤0.01% | 3352 |
|
Dimensional Fund Advisors's KZR Position: Q2 2026 in Review
Dimensional Fund Advisors sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 30,334 shares — an estimated $225K sold.
Dimensional Fund Advisors first reported a position in KZR in Q2 2021 and held it in 15 quarters. The position peaked at $6.09M in Q3 2022. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.
- Dimensional Fund Advisors reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
- Dimensional Fund Advisors sold 30,334 Kezar Life Sciences shares in Q2 2026, an estimated $225K.
- Dimensional Fund Advisors first reported a position in Kezar Life Sciences in Q2 2021 and held it in 15 quarters.
- Dimensional Fund Advisors's Kezar Life Sciences position peaked at $6.09M in Q3 2022.
- 0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.